Alpha DNA Investment Management’s NIO NIO Stock Holding History

Alpha DNA Investment Management’s Portfolio NIO Stock Details NIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-22	Closed	–	–	445
2021 Q1	$0	Sell	22 -4	-15%	-$204	﹤0.01%	751
2020 Q4	$1K	Buy	+26	New	+$1.01K	﹤0.01%	535

Other funds holding NIO

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Alpha DNA Investment Management's NIO Position: Q2 2021 in Review

Alpha DNA Investment Management sold out of NIO (NIO) in Q2 2021, closing a stake of 22 shares.

Alpha DNA Investment Management first reported a position in NIO in Q4 2020 and held it in 2 quarters. The position peaked at $1K in Q4 2020. 661 funds tracked by Wall St. Rank hold NIO as of Q2 2021.

Alpha DNA Investment Management reported no remaining NIO position as of Q2 2021 after selling out during the quarter.
Alpha DNA Investment Management sold 22 NIO shares in Q2 2021.
Alpha DNA Investment Management first reported a position in NIO in Q4 2020 and held it in 2 quarters.
Alpha DNA Investment Management's NIO position peaked at $1K in Q4 2020.
661 funds tracked by Wall St. Rank held NIO as of Q2 2021.

Based on Alpha DNA Investment Management's 13F filing for Q2 2021, filed 10 Aug 2021.